drugset / Trial / NCT00144651
Study of MRA in Patients With Rheumatoid Arthritis (RA)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is an open-label, extension, Phase II study to evaluate the long-term safety and efficacy of MRA in Patients with RA who were participated in Study MRA009JP.
Timeline
- Start
- 2001-08
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tocilizumab | Monoclonal antibody | 8 mg/kg | — |